Jacobs Levy Equity Management, Inc Tenaya Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 337,265 shares of TNYA stock, worth $536,251. This represents 0.0% of its overall portfolio holdings.
Number of Shares
337,265
Previous 110,799
204.39%
Holding current value
$536,251
Previous $343,000
89.5%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$14.9 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$11.1 Million0.19% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$10.7 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$6.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$5.11 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $65.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...